Seattle Genetics and Astellas Initiate Pivotal Trial of Enfortumab Vedotin for Patients with Locally Advanced or Metastatic Urothelial Cancer
Seattle Genetics, Inc. and Astellas Pharma Inc. announced dosing of the first patient in EV-201, a registrational phase 2 clinical trial of enfortumab vedotin...
Exelixis Provides Update on Collaborator Daiichi Sankyo’s Phase 3 Clinical Progress with Esaxerenone
Exelixis, Inc. announced that its partner Daiichi Sankyo Company, Limited (“Daiichi Sankyo”) has reported positive top-line results from a phase 3 pivotal trial of...
Juno Therapeutics Opens New Headquarters and Research Center
Juno Therapeutics, Inc. a biopharmaceutical company developing innovative cellular immunotherapies for the treatment of cancer, today unveiled its new headquarters and research facility, located...
Trelegy Ellipta approved as single inhaler triple therapy for the treatment of appropriate patients with COPD in the US
GlaxoSmithKline plc and Innoviva, Inc. (NASDAQ: INVA) today announced that the US Food and Drug Administration (FDA) has approved once-daily, single inhaler triple therapy...
Kaneka’s CDMO Eurogentec to build new biologics manufacturing plant in Belgium
Belgium-based CDMO Kaneka Eurogentec, a unit of Japanese chemical giant Kaneka, will build a new biologics manufacturing facility as part of the company’s expansion...
Novartis’ Cosentyx sets new benchmark in psoriasis with robust 5-year sustained phase III efficacy & safety data
Novartis announced, first of its kind phase III data showing Cosentyx (secukinumab) delivered high and long-lasting skin clearance in patients with moderate-to-severe plaque psoriasis...
Dr Reddy’s Labs subsidiary Aurigene and Curis to initiate phase 2 trial of PDL1-VISTA inhibitor ‘CA-170’ in India
Aurigene Discovery Technologies Ltd, a wholly owned subsidiary of Dr. Reddy’s Laboratories Ltd and Curis, Inc. have announced plans to initiate a Phase 2...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...